Zymeworks Completes Acquisition of Theravance Biopharma
Conference call with Zymeworks management on September 28 at 8:30 am Eastern Time (ET)VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare
